552 related articles for article (PubMed ID: 19929975)
1. Single-dose extended-release oral azithromycin vs. 3-day azithromycin for the treatment of group A beta-haemolytic streptococcal pharyngitis/tonsillitis in adults and adolescents: a double-blind, double-dummy study.
Jorgensen DM
Clin Microbiol Infect; 2009 Dec; 15(12):1103-10. PubMed ID: 19929975
[TBL] [Abstract][Full Text] [Related]
2. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
3. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis.
Cohen R
Pediatr Infect Dis J; 2004 Feb; 23(2 Suppl):S129-34. PubMed ID: 14770076
[TBL] [Abstract][Full Text] [Related]
4. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 5 days of extended-release clarithromycin versus 10 days of penicillin V for the treatment of streptococcal pharyngitis/tonsillitis: results of a multicenter, double-blind, randomized study in adolescent and adult patients.
Takker U; Dzyublyk O; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):421-9. PubMed ID: 13678479
[TBL] [Abstract][Full Text] [Related]
6. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
Casey JR; Pichichero ME
Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
[TBL] [Abstract][Full Text] [Related]
7. Cefaclor AF in the treatment of streptococcal pharyngitis/tonsillitis.
Derriennic M; Voi M; Thoren LM; Black SA; Dere WH
Postgrad Med J; 1992; 68 Suppl 3():S43-6; discussion S46-8. PubMed ID: 1287618
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin versus penicillin V in the treatment of paediatric patients with acute streptococcal pharyngitis/tonsillitis. Paediatric Azithromycin Study Group.
O'Doherty B
Eur J Clin Microbiol Infect Dis; 1996 Sep; 15(9):718-24. PubMed ID: 8922571
[TBL] [Abstract][Full Text] [Related]
9. Macrolide therapy of group A streptococcal pharyngitis: 10 days of macrolide therapy (clarithromycin) is more effective in streptococcal eradication than 5 days (azithromycin).
Kaplan EL; Gooch III WM; Notario GF; Craft JC
Clin Infect Dis; 2001 Jun; 32(12):1798-802. PubMed ID: 11360224
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 5-day therapy with telithromycin, a novel ketolide antibacterial, for the treatment of tonsillopharyngitis.
Norrby SR; Quinn J; Rangaraju M; Leroy B
Clin Microbiol Infect; 2004 Jul; 10(7):615-23. PubMed ID: 15214873
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
Bereznoy VV; Riley DS; Wassmer G; Heger M
Altern Ther Health Med; 2003; 9(5):68-79. PubMed ID: 14526713
[TBL] [Abstract][Full Text] [Related]
13. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults.
McCarty J; Hernon Y; Linn L; Therasse DG; Molina A; Bleile N
Clin Ther; 1992; 14(1):30-40. PubMed ID: 1576624
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness and tolerance of cefixime in comparison with penicillin V in bacterial pharyngitis and tonsillitis in children. Cefixime Study Group].
Adam D; Hostalek U
Klin Padiatr; 1994; 206(1):26-9. PubMed ID: 8152203
[TBL] [Abstract][Full Text] [Related]
15. [Use of azithromycin in ORL].
Gehanno P
Pathol Biol (Paris); 1995 Jun; 43(6):530-3. PubMed ID: 8539077
[TBL] [Abstract][Full Text] [Related]
16. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
17. Bacterial eradication rates with shortened courses of 2nd- and 3rd-generation cephalosporins versus 10 days of penicillin for treatment of group A streptococcal tonsillopharyngitis in adults.
Pichichero ME; Casey JR
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):127-30. PubMed ID: 17908614
[TBL] [Abstract][Full Text] [Related]
18. Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study.
File TM; Mandell LA; Tillotson G; Kostov K; Georgiev O
J Antimicrob Chemother; 2007 Jul; 60(1):112-20. PubMed ID: 17537866
[TBL] [Abstract][Full Text] [Related]
19. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of azithromycin in serum and sinus fluid after administration of extended-release and immediate-release formulations in patients with acute bacterial sinusitis.
Ehnhage A; Rautiainen M; Fang AF; Sanchez SP
Int J Antimicrob Agents; 2008 Jun; 31(6):561-6. PubMed ID: 18456465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
